三重治疗与中度至重度喘的双吸入器治疗:更新的系统性审查和元分析
Daniel G Rayner1, Layla Bakaa2, Flavia Hoyte3
1Evidence in Allergy Group, McMaster University, Hamilton, ON, Canada; Schulich School of Medicine & Dentistry, Western University, London, ON, Canada.
概括
三重疗法 (吸入性皮质类固醇,长效β-激动剂和长效肌酸抗剂) 在高风险患者中显著降低了严重的喘恶化. 与双重治疗相比,这种方法提供了最小的伤害和轻微改善喘控制和生活质量.
科学领域:
- 肺病学和呼吸系统医学
- 临床药理学 临床药理学
- 基于证据的医学基于证据的医学.
背景情况:
- 吸入性皮质类固醇 (ICS) 和长效β-激动剂 (LABA) 是标准的喘治疗方法.
- 长效肌抗体 (LAMA) 越来越多地被添加到ICS/LABA中,以加强喘管理.
研究的目的:
- 系统地审查喘三重治疗 (ICS/LABA/LAMA) 与双重治疗 (ICS/LABA) 的益处和危害.
- 为发展有关喘管理的AAAAI/ACAAI临床指南提供信息.
主要方法:
- 从2020年1月到2025年2月的随机对照试验 (RCT) 的系统审查和元分析.
- 在多个数据库中进行了搜索 (MEDLINE,Embase,CENTRAL,ICTRP).
- 使用随机效应模型和GRADE确定性评估评估喘控制,生活质量,FEV1,恶化和不良事件.
主要成果:
- 三重治疗显著减少了高风险患者的严重恶化 (RR 0.83,高确定性).
- 在喘控制 (MD -0.04,中等确定性) 和生活质量 (MD 0.05,中等确定性) 中观察到的最小改善.
- 没有注意到严重不良事件的显著增加 (中等确定性).
结论:
- 对于中度至重度的喘,三重疗法有效地减少了高风险个体的严重恶化.
- 与双重治疗相比,三重治疗的好处是通过最小的额外伤害实现的.
- 研究结果支持在特定的喘患者群体中使用三重疗法.
相关概念视频
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Inhaled Medications
244
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
244
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
254
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
254
COPD: Management Using Bronchodilators and Corticosteroids
190
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
190
Antiasthma Drugs: β2-Adrenoceptor Agonists
241
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
241
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
230
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
230


